Sabby Management, LLC In Med Pharmaceuticals Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.22 - $0.37 $11,988 - $20,162	-54,492 Reduced 15.06%	307,236 $82,000
Q1 2024 May 15, 2024	SELL	$0.32 - $0.44 $48,065 - $66,090	-150,206 Reduced 29.34%	361,728 $130,000
Q4 2023 Feb 14, 2024	BUY	$0.33 - $0.99 $168,938 - $506,814	511,934 New	511,934 $215,000
Q3 2022 Nov 14, 2022	BUY	$5.11 - $18.78 $78,101 - $287,033	15,284 New	15,284 $101,000

1.14M

Ticker INM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 908,761
Market Cap $4.71M
Description
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.